lovastatin has been researched along with Alloxan Diabetes in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Lau-Cam, CA; Pandya, K | 1 |
| Cao, YC; Liang, J; Sun, RL; Tang, CR; Wang, YX; Xu, LM; Yang, F; Ye, Z; Yu, XB; Zhang, HN | 1 |
| Hosseinpour, F; Rafieian-Kopaei, M; Shomali, T | 1 |
| Bentinger, M; Brismar, K; Chojnacki, T; Dallner, G; Danikiewicz, W; Kaczorowska, E; Kania, M; Swiezewska, E; Tekle, M; Wojcik, J | 1 |
| Chen, Y; Chen, YG; Guo, T; Jia, M; Li, P; Liang, WJ; Liu, LY; Ma, H; Peng, QS; Shan, MR; Sun, XY; Wang, F; Wang, SX; Wang, XQ; Yang, JJ; Yin, YL; Zhang, JN | 1 |
| Chen, D; Li, J; Ma, JX; Mott, R; Wang, JJ; Yu, Q; Zhang, SX | 1 |
| Duan, HJ; He, N; Liu, QJ; Liu, SX; Shi, YH; Wang, LH | 1 |
| Duan, HJ; Liu, QJ; Shi, YH; Wang, LH | 1 |
| Farrokhfall, K; Fatehi, M; Fatehi-Hassanabad, Z; Imen-Shahidi, M; Parsaeei, H | 1 |
| Cha, MK; Han, DC; Hwang, SD; Kim, JH; Lee, HB; Song, KI | 1 |
| Kazumi, T; Maeda, E; Matsushita, M; Morita, M; Murata, Y; Nagata, K; Naka, Y; Yoshino, G | 1 |
| Brouhard, BH; Cressman, MD; Inman, SR; Nally, JV; Satodate, R; Satoh, S; Stowe, NT; Vidt, DG | 1 |
| Han, DC; Kim, SI; Lee, HB | 1 |
| El-Swefy, S; El-Sweidy, M; Meydani, M; Ordovas, JM; Schaefer, EJ; Seman, LJ; Sevanian, A; Smith, DE; van Dongen, D | 1 |
| Alberts, AW; Chan, IF; Gleeson, JM; Hejazi, JS; Kwong, L; Le, T; Wilson, DE | 1 |
15 other study(ies) available for lovastatin and Alloxan Diabetes
| Article | Year |
|---|---|
Taurine Improves the Actions of Metformin and Lovastatin on Plasma Markers of Carbohydrate and Lipid Dysfunction of Diabetic Rats.
Topics: Animals; Blood Glucose; Carbohydrates; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Insulin; Lipids; Lovastatin; Male; Metformin; Rats; Rats, Sprague-Dawley; Streptozocin; Taurine | 2019 |
Lovastatin Prevents Depressive Behaviors and Increased Hippocampal Neurogenesis in Streptozotocin-Induced Diabetic Mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Depression; Diabetes Mellitus, Experimental; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mice; Mice, Inbred C57BL; Neurogenesis; Stress, Psychological | 2020 |
Hypocholesterolemic activity of cornelian cherry (Cornus mas L.) fruits.
Topics: Animals; Anticholesteremic Agents; Antioxidants; Blood Glucose; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cornaceae; Diabetes Mellitus, Experimental; Fruit; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Liver; Lovastatin; Male; Phytotherapy; Plant Extracts; Powders; Rats, Wistar | 2017 |
Effects of various squalene epoxides on coenzyme Q and cholesterol synthesis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cholesterol; Diabetes Mellitus, Experimental; Etidronic Acid; Hemiterpenes; Hep G2 Cells; Humans; Lovastatin; Male; Mevalonic Acid; Mice; Mice, Inbred C57BL; Mice, Knockout; Organophosphorus Compounds; Rats; Rats, Wistar; Risedronic Acid; Squalene; Tricarboxylic Acids; Ubiquinone | 2014 |
Lovastatin upregulates microRNA-29b to reduce oxidative stress in rats with multiple cardiovascular risk factors.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Aorta; Cardiovascular Diseases; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Dyslipidemias; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperhomocysteinemia; Lovastatin; MicroRNAs; Nuclear Proteins; Oxidative Stress; Proteasome Endopeptidase Complex; RNA Interference; Signal Transduction; Time Factors; Transfection; Up-Regulation; Vasodilation | 2017 |
Systemic administration of HMG-CoA reductase inhibitor protects the blood-retinal barrier and ameliorates retinal inflammation in type 2 diabetes.
Topics: Animals; Blood-Retinal Barrier; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Drug Evaluation, Preclinical; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Intercellular Adhesion Molecule-1; Lipids; Lovastatin; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Retina; Retinal Pigment Epithelium; Tight Junctions; Tumor Necrosis Factor-alpha | 2009 |
[Effects of lovastatin on renal function and expression of phosphorylating-p38 mitogen-activated protein kinase in experimental diabetic nephropathy in rats].
Topics: Animals; Cyclic AMP Response Element-Binding Protein; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Kidney; Kidney Function Tests; Kidney Glomerulus; Lovastatin; Male; p38 Mitogen-Activated Protein Kinases; Random Allocation; Rats; Rats, Wistar; Signal Transduction | 2004 |
[Protective effects of Lovastatin on early diabetic renal tissue and the possible mechanism].
Topics: Activating Transcription Factor 2; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney Function Tests; Lovastatin; Male; Protective Agents; Rats; Rats, Wistar | 2005 |
The beneficial in vitro effects of lovastatin and chelerythrine on relaxatory response to acetylcholine in the perfused mesentric bed isolated from diabetic rats.
Topics: Acetylcholine; Alkaloids; Animals; Benzophenanthridines; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Lovastatin; Male; Mesenteric Arteries; Nitroprusside; Perfusion; Phenanthridines; Phenylephrine; Protein Kinase C; Rats; Rats, Wistar; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2006 |
Effect of HMG CoA reductase inhibition on TGF-beta 1 mRNA expression in diabetic rat glomeruli.
Topics: Animals; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney Glomerulus; Lovastatin; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta | 1995 |
Effect of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor on triglyceride kinetics in chronically streptozotocin-diabetic rats.
Topics: Animals; Cholesterol; Chronic Disease; Diabetes Mellitus, Experimental; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Lipids; Lovastatin; Male; Rats; Rats, Wistar; Reference Values; Simvastatin; Triglycerides | 1993 |
Lovastatin preserves renal function in experimental diabetes.
Topics: Animals; Anticholesteremic Agents; Antihypertensive Agents; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Glomerular Filtration Rate; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Kidney Function Tests; Lovastatin; Male; Rats; Rats, Wistar; Triglycerides | 1999 |
Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells.
Topics: Albuminuria; Animals; Blood Glucose; Cells, Cultured; Cholesterol; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Fibronectins; Glomerular Mesangium; Kidney Glomerulus; Lovastatin; Male; Mevalonic Acid; Organ Size; Protein Biosynthesis; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin; Transforming Growth Factor beta | 2000 |
The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
Topics: Animals; Animals, Newborn; Anticholesteremic Agents; Antioxidants; Arteriosclerosis; Cells, Cultured; Cricetinae; Diabetes Mellitus, Experimental; Disease Models, Animal; Foam Cells; Hyperlipidemias; Lipid Peroxidation; Lovastatin; Male; Mesocricetus; Probucol; Reference Values; Streptozocin; Vitamin E | 2000 |
Plasma apolipoprotein E, high density lipoprotein1 (HDL1) and urinary mevalonate excretion in pancreatectomized diabetic dogs: effects of insulin and lovastatin.
Topics: Animals; Apolipoproteins B; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Dogs; Insulin; Lipoproteins, HDL; Lovastatin; Male; Mevalonic Acid; Pancreatectomy | 1990 |